News

Students in the Class of 2025 learned on Match Day where they will be doing their internship and residency training—setting the stage for the next several years of their medical careers and lives.

The Cornell Board of Trustees today voted to appoint Michael I. Kotlikoff, who has served as interim president since July 2024, Cornell’s 15th president, effective immediately.

An program developed by NewYork-Presbyterian and Weill Cornell Medicine that combines physician telehealth with home health care administered by paramedics helps reduce hospital readmissions for patients with heart failure and other chronic conditions, according to new research.

Students from Cornell’s Master of Public Health program and faculty from Weill Cornell Medicine’s Department of Pediatrics recently joined forces at the United Nations Foundation’s Shot@Life Advocate to Vaccinate Summit to champion global vaccine access.

A generous grant from The Hearst Foundations will fund a new Program for the Study and Support of Caregivers at Weill Cornell Medicine, developing new strategies to help people cope with the challenges of caring for friends or family members at home.

Weill Cornell Medicine researchers found that restricting telehealth prescriptions for opioid use disorder could prevent thousands from accessing buprenorphine, a medication that helps people recover from addiction.

Dr. Jim Hu was awarded a grant from the Prevent Cancer Foundation to support and innovate initiatives aimed at reducing misinformation, improving patient decision making, and addressing disparities in prostate cancer diagnosis and treatment.

A person’s “bioenergetic age” — or how youthfully their cells generate energy — might be a key indicator of whether they’re at risk of developing Alzheimer’s disease, new research from Weill Cornell Medicine shows.

A new Weill Cornell Medicine and Oregon Health & Science University co-authored study provides critical insight for the development of a vaccine that can more effectively block the spread of cytomegalovirus, or CMV, across the placenta to babies before they are born.

Tuberculosis bacteria rely on a family of genes that help them survive the challenging journey from one person’s lungs to another person’s during coughing, sneezing or talking, according to researchers from Weill Cornell Medicine and the Massachusetts Institute of Technology.

A single molecular switch is essential for blood stem cells to enter an activated, regenerative state in which they produce new blood cells, according to a preclinical study led by Weill Cornell Medicine investigators.

Dr. Jacqueline Burré and a team of researchers were recently awarded an R01 grant from the National Institute of Neurological Disorders and Stroke expected to be $3.9 million over five years. 

The Weill Cornell Medicine Department of Neurological Surgery has made a major advancement in its Tanzania Neurosurgery Program by launching the region’s first dedicated endoscopy training program. The course provided a hands-on training experience for local surgeons, furthering the program’s commitment to enhancing neurosurgical care in East Africa.  

People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a potential biomarker, according to new study by Weill Cornell Medicine researchers.

A new study unveils a precise picture of how an ion channel found in most mammalian cells regulates its own function with a “ball-and-chain” channel-plugging mechanism. The findings could lead to new drugs that target these channels to treat disorders such as epilepsy and hypertension.

In his new role, Dr. Safdieh will lead the institution’s Office of Medical Education and oversee the overall living and learning experience of Weill Cornell Medical College’s students.

Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education.

Dr. Heidi Bender, professor of...

A new AI-based system for analyzing images taken over time can accurately detect changes and predict outcomes, according to a study led by investigators at Weill Cornell Medicine, Cornell’s Ithaca campus and Cornell Tech.

Working toward more effective tuberculosis (TB) vaccines, researchers have developed two strains of mycobacteria with "kill switches" that can be triggered to stop the bacteria after they activate an immune response.